{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 733541, "items": [{"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T21:21:37Z", "timestamp": 1576790497886}, "reference-count": 23, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "11", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2004, 6, 1]]}, "abstract": "<jats:sec><jats:title>Purpose</jats:title><jats:p> Capecitabine has demonstrated high efficacy as first-line treatment for metastatic colorectal cancer (MCRC). Oxaliplatin shows synergy with fluorouracil (FU), with little toxicity overlap. The XELOX regimen (capecitabine plus oxaliplatin), established in a previous dose-finding study, should improve on infused oxaliplatin with FU and leucovorin (FOLFOX) regimens. The present studies further characterize efficacy and safety of the XELOX regimen. </jats:p></jats:sec><jats:sec><jats:title>Patients and Methods</jats:title><jats:p> The antitumor activity of XELOX was investigated in a colon cancer xenograft model. Patients with MCRC received first-line XELOX in 3-week treatment cycles: intravenous oxaliplatin 130 mg/m<jats:sup>2</jats:sup> (day 1) followed by oral capecitabine 1,000 mg/m<jats:sup>2</jats:sup> twice daily (day 1, evening, to day 15, morning). </jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p> A preclinical study confirmed that capecitabine has supra-additive activity with oxaliplatin. In the clinical study, 53 of 96 patients (55%) achieved an objective response, and 30 (31%) experienced disease stabilization for \u2265 3 months following treatment. After 24 months' minimum follow-up, median time to disease progression (TTP) and median overall survival were 7.7 and 19.5 months, respectively. XELOX safety was predictable and similar to the FOLFOX4 regimen, except that myelosuppression was uncommon with XELOX (grade 3 or 4 neutropenia, 7%). Most adverse events were mild to moderate, the most common being acute sensory neuropathy (85%). Sixty-day, all-cause mortality was 2%. </jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p> XELOX is a highly effective first-line treatment for MCRC. Response rates, TTP, and overall survival are similar to those observed with FU/leucovorin/oxaliplatin combinations. XELOX provides a more convenient regimen, likely to be preferred by both patients and healthcare providers. Capecitabine has the potential to replace FU/LV in combination with oxaliplatin for MCRC. </jats:p></jats:sec>", "DOI": "10.1200/jco.2004.11.069", "type": "journal-article", "created": {"date-parts": [[2004, 5, 28]], "date-time": "2004-05-28T23:08:15Z", "timestamp": 1085785695000}, "page": "2084-2091", "source": "Crossref", "is-referenced-by-count": 322, "title": ["XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer"], "prefix": "10.1200", "volume": "22", "author": [{"given": "Jim", "family": "Cassidy", "sequence": "first", "affiliation": [{"name": "From the Department of Medicine and Therapeutics, Aberdeen; Beatson Oncology Centre, Glasgow; University of Leeds and Tom Connors Cancer Research Centre, Bradford, United Kingdom; Hospital Vall d'Hebr\u00f3n University Hospital, Barcelona; Hospital Cl\u00ednico San Carlos Servicio de Oncolog\u00eda, Madrid, Spain; Institut Bergonie, Bordeaux; Centre Alexis Vautrin, Nancy, France; Cross Cancer Institute, Edmonton, Canada; European Institute of Oncology, Milan; Clinica Oncologica, Udine, Italy; Sourasky Medical Center,..."}]}, {"given": "Josep", "family": "Tabernero", "sequence": "additional", "affiliation": [{"name": "From the Department of Medicine and Therapeutics, Aberdeen; Beatson Oncology Centre, Glasgow; University of Leeds and Tom Connors Cancer Research Centre, Bradford, United Kingdom; Hospital Vall d'Hebr\u00f3n University Hospital, Barcelona; Hospital Cl\u00ednico San Carlos Servicio de Oncolog\u00eda, Madrid, Spain; Institut Bergonie, Bordeaux; Centre Alexis Vautrin, Nancy, France; Cross Cancer Institute, Edmonton, Canada; European Institute of Oncology, Milan; Clinica Oncologica, Udine, Italy; Sourasky Medical Center,..."}]}, {"given": "Chris", "family": "Twelves", "sequence": "additional", "affiliation": [{"name": "From the Department of Medicine and Therapeutics, Aberdeen; Beatson Oncology Centre, Glasgow; University of Leeds and Tom Connors Cancer Research Centre, Bradford, United Kingdom; Hospital Vall d'Hebr\u00f3n University Hospital, Barcelona; Hospital Cl\u00ednico San Carlos Servicio de Oncolog\u00eda, Madrid, Spain; Institut Bergonie, Bordeaux; Centre Alexis Vautrin, Nancy, France; Cross Cancer Institute, Edmonton, Canada; European Institute of Oncology, Milan; Clinica Oncologica, Udine, Italy; Sourasky Medical Center,..."}]}, {"given": "Ren\u00e9", "family": "Brunet", "sequence": "additional", "affiliation": [{"name": "From the Department of Medicine and Therapeutics, Aberdeen; Beatson Oncology Centre, Glasgow; University of Leeds and Tom Connors Cancer Research Centre, Bradford, United Kingdom; Hospital Vall d'Hebr\u00f3n University Hospital, Barcelona; Hospital Cl\u00ednico San Carlos Servicio de Oncolog\u00eda, Madrid, Spain; Institut Bergonie, Bordeaux; Centre Alexis Vautrin, Nancy, France; Cross Cancer Institute, Edmonton, Canada; European Institute of Oncology, Milan; Clinica Oncologica, Udine, Italy; Sourasky Medical Center,..."}]}, {"given": "Charles", "family": "Butts", "sequence": "additional", "affiliation": [{"name": "From the Department of Medicine and Therapeutics, Aberdeen; Beatson Oncology Centre, Glasgow; University of Leeds and Tom Connors Cancer Research Centre, Bradford, United Kingdom; Hospital Vall d'Hebr\u00f3n University Hospital, Barcelona; Hospital Cl\u00ednico San Carlos Servicio de Oncolog\u00eda, Madrid, Spain; Institut Bergonie, Bordeaux; Centre Alexis Vautrin, Nancy, France; Cross Cancer Institute, Edmonton, Canada; European Institute of Oncology, Milan; Clinica Oncologica, Udine, Italy; Sourasky Medical Center,..."}]}, {"given": "Thierry", "family": "Conroy", "sequence": "additional", "affiliation": [{"name": "From the Department of Medicine and Therapeutics, Aberdeen; Beatson Oncology Centre, Glasgow; University of Leeds and Tom Connors Cancer Research Centre, Bradford, United Kingdom; Hospital Vall d'Hebr\u00f3n University Hospital, Barcelona; Hospital Cl\u00ednico San Carlos Servicio de Oncolog\u00eda, Madrid, Spain; Institut Bergonie, Bordeaux; Centre Alexis Vautrin, Nancy, France; Cross Cancer Institute, Edmonton, Canada; European Institute of Oncology, Milan; Clinica Oncologica, Udine, Italy; Sourasky Medical Center,..."}]}, {"given": "Filippo", "family": "Debraud", "sequence": "additional", "affiliation": [{"name": "From the Department of Medicine and Therapeutics, Aberdeen; Beatson Oncology Centre, Glasgow; University of Leeds and Tom Connors Cancer Research Centre, Bradford, United Kingdom; Hospital Vall d'Hebr\u00f3n University Hospital, Barcelona; Hospital Cl\u00ednico San Carlos Servicio de Oncolog\u00eda, Madrid, Spain; Institut Bergonie, Bordeaux; Centre Alexis Vautrin, Nancy, France; Cross Cancer Institute, Edmonton, Canada; European Institute of Oncology, Milan; Clinica Oncologica, Udine, Italy; Sourasky Medical Center,..."}]}, {"given": "Arie", "family": "Figer", "sequence": "additional", "affiliation": [{"name": "From the Department of Medicine and Therapeutics, Aberdeen; Beatson Oncology Centre, Glasgow; University of Leeds and Tom Connors Cancer Research Centre, Bradford, United Kingdom; Hospital Vall d'Hebr\u00f3n University Hospital, Barcelona; Hospital Cl\u00ednico San Carlos Servicio de Oncolog\u00eda, Madrid, Spain; Institut Bergonie, Bordeaux; Centre Alexis Vautrin, Nancy, France; Cross Cancer Institute, Edmonton, Canada; European Institute of Oncology, Milan; Clinica Oncologica, Udine, Italy; Sourasky Medical Center,..."}]}, {"given": "Johannes", "family": "Grossmann", "sequence": "additional", "affiliation": [{"name": "From the Department of Medicine and Therapeutics, Aberdeen; Beatson Oncology Centre, Glasgow; University of Leeds and Tom Connors Cancer Research Centre, Bradford, United Kingdom; Hospital Vall d'Hebr\u00f3n University Hospital, Barcelona; Hospital Cl\u00ednico San Carlos Servicio de Oncolog\u00eda, Madrid, Spain; Institut Bergonie, Bordeaux; Centre Alexis Vautrin, Nancy, France; Cross Cancer Institute, Edmonton, Canada; European Institute of Oncology, Milan; Clinica Oncologica, Udine, Italy; Sourasky Medical Center,..."}]}, {"given": "Noriaki", "family": "Sawada", "sequence": "additional", "affiliation": [{"name": "From the Department of Medicine and Therapeutics, Aberdeen; Beatson Oncology Centre, Glasgow; University of Leeds and Tom Connors Cancer Research Centre, Bradford, United Kingdom; Hospital Vall d'Hebr\u00f3n University Hospital, Barcelona; Hospital Cl\u00ednico San Carlos Servicio de Oncolog\u00eda, Madrid, Spain; Institut Bergonie, Bordeaux; Centre Alexis Vautrin, Nancy, France; Cross Cancer Institute, Edmonton, Canada; European Institute of Oncology, Milan; Clinica Oncologica, Udine, Italy; Sourasky Medical Center,..."}]}, {"given": "Patrick", "family": "Sch\u00f6ffski", "sequence": "additional", "affiliation": [{"name": "From the Department of Medicine and Therapeutics, Aberdeen; Beatson Oncology Centre, Glasgow; University of Leeds and Tom Connors Cancer Research Centre, Bradford, United Kingdom; Hospital Vall d'Hebr\u00f3n University Hospital, Barcelona; Hospital Cl\u00ednico San Carlos Servicio de Oncolog\u00eda, Madrid, Spain; Institut Bergonie, Bordeaux; Centre Alexis Vautrin, Nancy, France; Cross Cancer Institute, Edmonton, Canada; European Institute of Oncology, Milan; Clinica Oncologica, Udine, Italy; Sourasky Medical Center,..."}]}, {"given": "Alberto", "family": "Sobrero", "sequence": "additional", "affiliation": [{"name": "From the Department of Medicine and Therapeutics, Aberdeen; Beatson Oncology Centre, Glasgow; University of Leeds and Tom Connors Cancer Research Centre, Bradford, United Kingdom; Hospital Vall d'Hebr\u00f3n University Hospital, Barcelona; Hospital Cl\u00ednico San Carlos Servicio de Oncolog\u00eda, Madrid, Spain; Institut Bergonie, Bordeaux; Centre Alexis Vautrin, Nancy, France; Cross Cancer Institute, Edmonton, Canada; European Institute of Oncology, Milan; Clinica Oncologica, Udine, Italy; Sourasky Medical Center,..."}]}, {"given": "Eric", "family": "Van Cutsem", "sequence": "additional", "affiliation": [{"name": "From the Department of Medicine and Therapeutics, Aberdeen; Beatson Oncology Centre, Glasgow; University of Leeds and Tom Connors Cancer Research Centre, Bradford, United Kingdom; Hospital Vall d'Hebr\u00f3n University Hospital, Barcelona; Hospital Cl\u00ednico San Carlos Servicio de Oncolog\u00eda, Madrid, Spain; Institut Bergonie, Bordeaux; Centre Alexis Vautrin, Nancy, France; Cross Cancer Institute, Edmonton, Canada; European Institute of Oncology, Milan; Clinica Oncologica, Udine, Italy; Sourasky Medical Center,..."}]}, {"given": "Eduardo", "family": "D\u00edaz-Rubio", "sequence": "additional", "affiliation": [{"name": "From the Department of Medicine and Therapeutics, Aberdeen; Beatson Oncology Centre, Glasgow; University of Leeds and Tom Connors Cancer Research Centre, Bradford, United Kingdom; Hospital Vall d'Hebr\u00f3n University Hospital, Barcelona; Hospital Cl\u00ednico San Carlos Servicio de Oncolog\u00eda, Madrid, Spain; Institut Bergonie, Bordeaux; Centre Alexis Vautrin, Nancy, France; Cross Cancer Institute, Edmonton, Canada; European Institute of Oncology, Milan; Clinica Oncologica, Udine, Italy; Sourasky Medical Center,..."}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.11.069", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T20:41:34Z", "timestamp": 1574887294000}, "score": 61.626423, "issued": {"date-parts": [[2004, 6, 1]]}, "references-count": 23, "journal-issue": {"published-print": {"date-parts": [[2004, 6, 1]]}, "issue": "11"}, "alternative-id": ["10.1200/JCO.2004.11.069"], "URL": "http://dx.doi.org/10.1200/jco.2004.11.069", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T21:22:58Z", "timestamp": 1576790578670}, "reference-count": 9, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "31", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2007, 11, 1]]}, "DOI": "10.1200/jco.2007.13.4676", "type": "journal-article", "created": {"date-parts": [[2007, 10, 30]], "date-time": "2007-10-30T22:48:02Z", "timestamp": 1193784482000}, "page": "5043-5045", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Capecitabine Plus Oxaliplatin in Metastatic Colorectal Cancer"], "prefix": "10.1200", "volume": "25", "author": [{"given": "Jim", "family": "Cassidy", "sequence": "first", "affiliation": [{"name": "Cancer Research UK, Department of Medical Oncology, University of Glasgow, Glasgow, Scotland"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2007.13.4676", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T20:07:52Z", "timestamp": 1574885272000}, "score": 58.722843, "issued": {"date-parts": [[2007, 11, 1]]}, "references-count": 9, "journal-issue": {"published-print": {"date-parts": [[2007, 11, 1]]}, "issue": "31"}, "alternative-id": ["10.1200/JCO.2007.13.4676"], "URL": "http://dx.doi.org/10.1200/jco.2007.13.4676", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T00:17:35Z", "timestamp": 1574122655920}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2002, 4, 1]]}, "DOI": "10.1093/annonc/mdf089", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T22:59:57Z", "timestamp": 1027724397000}, "page": "566-575", "source": "Crossref", "is-referenced-by-count": 322, "title": ["First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin"], "prefix": "10.1093", "volume": "13", "author": [{"given": "J.", "family": "Cassidy", "sequence": "first", "affiliation": []}], "member": "286", "container-title": ["Annals of Oncology"], "link": [{"URL": "http://academic.oup.com/annonc/article-pdf/13/4/566/560955/mdf089.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 22]], "date-time": "2017-08-22T16:31:04Z", "timestamp": 1503419464000}, "score": 54.32335, "issued": {"date-parts": [[2002, 4, 1]]}, "references-count": 0, "journal-issue": {"issue": "4"}, "URL": "http://dx.doi.org/10.1093/annonc/mdf089", "ISSN": ["0923-7534", "1569-8041"], "issn-type": [{"value": "0923-7534", "type": "print"}, {"value": "1569-8041", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:54:51Z", "timestamp": 1576799691653}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "14_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2004, 7, 15]]}, "DOI": "10.1200/jco.2004.22.14_suppl.3555", "type": "journal-article", "created": {"date-parts": [[2017, 4, 5]], "date-time": "2017-04-05T08:02:15Z", "timestamp": 1491379335000}, "page": "3555-3555", "source": "Crossref", "is-referenced-by-count": 0, "title": ["XELOX (capecitabine plus oxaliplatin), a safe and active first-line regimen for elderly patients with metastatic colorectal cancer (MCRC): Post-hoc analysis of a large phase II study"], "prefix": "10.1200", "volume": "22", "author": [{"given": "C.", "family": "Twelves", "sequence": "first", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "C.", "family": "Butts", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "J.", "family": "Cassidy", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "T.", "family": "Conroy", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "F.", "family": "De Braud", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "E.", "family": "D\u00edaz-Rubio", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "J.", "family": "Tabernero", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "P.", "family": "Sch\u00f6ffski", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "A.", "family": "Figer", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "E.", "family": "Van Cutsem", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.14_suppl.3555", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T22:04:11Z", "timestamp": 1574892251000}, "score": 52.802254, "issued": {"date-parts": [[2004, 7, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 7, 15]]}, "issue": "14_suppl"}, "alternative-id": ["10.1200/jco.2004.22.14_suppl.3555"], "URL": "http://dx.doi.org/10.1200/jco.2004.22.14_suppl.3555", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:55:56Z", "timestamp": 1576799756850}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "14_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2004, 7, 15]]}, "DOI": "10.1200/jco.2004.22.90140.3555", "type": "journal-article", "created": {"date-parts": [[2017, 4, 5]], "date-time": "2017-04-05T07:17:42Z", "timestamp": 1491376662000}, "page": "3555-3555", "source": "Crossref", "is-referenced-by-count": 0, "title": ["XELOX (capecitabine plus oxaliplatin), a safe and active first-line regimen for elderly patients with metastatic colorectal cancer (MCRC): Post-hoc analysis of a large phase II study"], "prefix": "10.1200", "volume": "22", "author": [{"given": "C.", "family": "Twelves", "sequence": "first", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "C.", "family": "Butts", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "J.", "family": "Cassidy", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "T.", "family": "Conroy", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "F.", "family": "De Braud", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "E.", "family": "D\u00edaz-Rubio", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "J.", "family": "Tabernero", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "P.", "family": "Sch\u00f6ffski", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "A.", "family": "Figer", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}, {"given": "E.", "family": "Van Cutsem", "sequence": "additional", "affiliation": [{"name": "Tom Connors Cancer Centre, University of Bradford, Bradford, United Kingdom; Cross Cancer Institute, Edmonton, AB, Canada; Glasgow University, Glasgow, United Kingdom; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France; European Institute of Oncology, Milan, Italy; Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain; Hospital General d'Hebr\u00f3n, Barcelona, Spain; Medizinische Hochschule Hannover, Hannover, Germany; Tel-Aviv Medical Center, Tel-Aviv, Israel; University Hospital Gasthuisberg, Leuven,..."}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.90140.3555", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T22:03:50Z", "timestamp": 1574892230000}, "score": 52.802254, "issued": {"date-parts": [[2004, 7, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 7, 15]]}, "issue": "14_suppl"}, "alternative-id": ["10.1200/jco.2004.22.90140.3555"], "URL": "http://dx.doi.org/10.1200/jco.2004.22.90140.3555", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:57:07Z", "timestamp": 1576799827346}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "16_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2005, 6]]}, "DOI": "10.1200/jco.2005.23.16_suppl.3596", "type": "journal-article", "created": {"date-parts": [[2017, 2, 23]], "date-time": "2017-02-23T18:55:09Z", "timestamp": 1487876109000}, "page": "3596-3596", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Phase III, randomized, open-label study of capecitabine (X) plus oxaliplatin (XELOX) vs. infusional 5-FU/LV plus oxaliplatin (FOLFOX-6) first-line treatment in patients (pts) with metastatic colorectal cancer (MCRC): Findings from an interim safety analysis"], "prefix": "10.1200", "volume": "23", "author": [{"given": "M.", "family": "Ducreux", "sequence": "first", "affiliation": [{"name": "Inst Gustave Roussy, Villejuif, France; Ctr Oscar Lambret, Lille, France; Ctr Ren\u00e9 Gauducheau, St. Herblain, France; Ctr Alexis Vautrin, Vandoeuvre-Les-Nancy, France; Ctr Hospitalier D\u00e9partemental, La Roche Sur Yon, France; H\u00f4pital Claude Huriez, Lille, France; Clin Saint-Jean, Lyon, France; H\u00f4pital Charles Nicolle, Rouen, France; Ctr Val d\u2019Aurelle, Montpellier, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France"}]}, {"given": "A.", "family": "Adenis", "sequence": "additional", "affiliation": [{"name": "Inst Gustave Roussy, Villejuif, France; Ctr Oscar Lambret, Lille, France; Ctr Ren\u00e9 Gauducheau, St. Herblain, France; Ctr Alexis Vautrin, Vandoeuvre-Les-Nancy, France; Ctr Hospitalier D\u00e9partemental, La Roche Sur Yon, France; H\u00f4pital Claude Huriez, Lille, France; Clin Saint-Jean, Lyon, France; H\u00f4pital Charles Nicolle, Rouen, France; Ctr Val d\u2019Aurelle, Montpellier, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France"}]}, {"given": "J.", "family": "Bennouna", "sequence": "additional", "affiliation": [{"name": "Inst Gustave Roussy, Villejuif, France; Ctr Oscar Lambret, Lille, France; Ctr Ren\u00e9 Gauducheau, St. Herblain, France; Ctr Alexis Vautrin, Vandoeuvre-Les-Nancy, France; Ctr Hospitalier D\u00e9partemental, La Roche Sur Yon, France; H\u00f4pital Claude Huriez, Lille, France; Clin Saint-Jean, Lyon, France; H\u00f4pital Charles Nicolle, Rouen, France; Ctr Val d\u2019Aurelle, Montpellier, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France"}]}, {"given": "T.", "family": "Conroy", "sequence": "additional", "affiliation": [{"name": "Inst Gustave Roussy, Villejuif, France; Ctr Oscar Lambret, Lille, France; Ctr Ren\u00e9 Gauducheau, St. Herblain, France; Ctr Alexis Vautrin, Vandoeuvre-Les-Nancy, France; Ctr Hospitalier D\u00e9partemental, La Roche Sur Yon, France; H\u00f4pital Claude Huriez, Lille, France; Clin Saint-Jean, Lyon, France; H\u00f4pital Charles Nicolle, Rouen, France; Ctr Val d\u2019Aurelle, Montpellier, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France"}]}, {"given": "R.", "family": "Faroux", "sequence": "additional", "affiliation": [{"name": "Inst Gustave Roussy, Villejuif, France; Ctr Oscar Lambret, Lille, France; Ctr Ren\u00e9 Gauducheau, St. Herblain, France; Ctr Alexis Vautrin, Vandoeuvre-Les-Nancy, France; Ctr Hospitalier D\u00e9partemental, La Roche Sur Yon, France; H\u00f4pital Claude Huriez, Lille, France; Clin Saint-Jean, Lyon, France; H\u00f4pital Charles Nicolle, Rouen, France; Ctr Val d\u2019Aurelle, Montpellier, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France"}]}, {"given": "M.", "family": "Hebbar", "sequence": "additional", "affiliation": [{"name": "Inst Gustave Roussy, Villejuif, France; Ctr Oscar Lambret, Lille, France; Ctr Ren\u00e9 Gauducheau, St. Herblain, France; Ctr Alexis Vautrin, Vandoeuvre-Les-Nancy, France; Ctr Hospitalier D\u00e9partemental, La Roche Sur Yon, France; H\u00f4pital Claude Huriez, Lille, France; Clin Saint-Jean, Lyon, France; H\u00f4pital Charles Nicolle, Rouen, France; Ctr Val d\u2019Aurelle, Montpellier, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France"}]}, {"given": "G.", "family": "Lledo", "sequence": "additional", "affiliation": [{"name": "Inst Gustave Roussy, Villejuif, France; Ctr Oscar Lambret, Lille, France; Ctr Ren\u00e9 Gauducheau, St. Herblain, France; Ctr Alexis Vautrin, Vandoeuvre-Les-Nancy, France; Ctr Hospitalier D\u00e9partemental, La Roche Sur Yon, France; H\u00f4pital Claude Huriez, Lille, France; Clin Saint-Jean, Lyon, France; H\u00f4pital Charles Nicolle, Rouen, France; Ctr Val d\u2019Aurelle, Montpellier, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France"}]}, {"given": "B.", "family": "Paillot", "sequence": "additional", "affiliation": [{"name": "Inst Gustave Roussy, Villejuif, France; Ctr Oscar Lambret, Lille, France; Ctr Ren\u00e9 Gauducheau, St. Herblain, France; Ctr Alexis Vautrin, Vandoeuvre-Les-Nancy, France; Ctr Hospitalier D\u00e9partemental, La Roche Sur Yon, France; H\u00f4pital Claude Huriez, Lille, France; Clin Saint-Jean, Lyon, France; H\u00f4pital Charles Nicolle, Rouen, France; Ctr Val d\u2019Aurelle, Montpellier, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France"}]}, {"given": "M.", "family": "Ychou", "sequence": "additional", "affiliation": [{"name": "Inst Gustave Roussy, Villejuif, France; Ctr Oscar Lambret, Lille, France; Ctr Ren\u00e9 Gauducheau, St. Herblain, France; Ctr Alexis Vautrin, Vandoeuvre-Les-Nancy, France; Ctr Hospitalier D\u00e9partemental, La Roche Sur Yon, France; H\u00f4pital Claude Huriez, Lille, France; Clin Saint-Jean, Lyon, France; H\u00f4pital Charles Nicolle, Rouen, France; Ctr Val d\u2019Aurelle, Montpellier, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France"}]}, {"given": "J. Y.", "family": "Douillard", "sequence": "additional", "affiliation": [{"name": "Inst Gustave Roussy, Villejuif, France; Ctr Oscar Lambret, Lille, France; Ctr Ren\u00e9 Gauducheau, St. Herblain, France; Ctr Alexis Vautrin, Vandoeuvre-Les-Nancy, France; Ctr Hospitalier D\u00e9partemental, La Roche Sur Yon, France; H\u00f4pital Claude Huriez, Lille, France; Clin Saint-Jean, Lyon, France; H\u00f4pital Charles Nicolle, Rouen, France; Ctr Val d\u2019Aurelle, Montpellier, France; Ctr Ren\u00e9 Gauducheau, Saint Herblain, France"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2005.23.16_suppl.3596", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:23:15Z", "timestamp": 1574889795000}, "score": 50.653923, "issued": {"date-parts": [[2005, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 6]]}, "issue": "16_suppl"}, "alternative-id": ["10.1200/jco.2005.23.16_suppl.3596"], "URL": "http://dx.doi.org/10.1200/jco.2005.23.16_suppl.3596", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T11:23:16Z", "timestamp": 1574335396030}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 9, 1]], "date-time": "2007-09-01T00:00:00Z", "timestamp": 1188604800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer Supplements"], "published-print": {"date-parts": [[2007, 9]]}, "DOI": "10.1016/s1359-6349(07)70940-0", "type": "journal-article", "created": {"date-parts": [[2007, 12, 1]], "date-time": "2007-12-01T05:40:31Z", "timestamp": 1196487631000}, "page": "238-239", "source": "Crossref", "is-referenced-by-count": 2, "title": ["3012 ORAL Capecitabine + oxaliplatin (XELOX) vs. 5-FU/LV + oxaliplatin (FOLFOX4) as second-line treatment for patients with metastatic colorectal cancer (MCRC): Phase III trial results"], "prefix": "10.1016", "volume": "5", "author": [{"given": "M.", "family": "Rothenberg", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Navarro", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Butts", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Bang", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Cox", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Goel", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Gollins", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Siu", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Cunningham", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1359634907709400?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1359634907709400?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 2]], "date-time": "2019-01-02T15:55:56Z", "timestamp": 1546444556000}, "score": 49.407764, "issued": {"date-parts": [[2007, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2007, 9]]}, "issue": "4"}, "alternative-id": ["S1359634907709400"], "URL": "http://dx.doi.org/10.1016/s1359-6349(07)70940-0", "ISSN": ["1359-6349"], "issn-type": [{"value": "1359-6349", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T22:19:20Z", "timestamp": 1574374760504}, "reference-count": 17, "publisher": "Oxford University Press (OUP)", "issue": "10", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Annals of Oncology"], "DOI": "10.1093/annonc/mdn370", "type": "journal-article", "created": {"date-parts": [[2008, 6, 13]], "date-time": "2008-06-13T00:24:30Z", "timestamp": 1213316670000}, "page": "1720-1726", "source": "Crossref", "is-referenced-by-count": 121, "title": ["Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study"], "prefix": "10.1093", "volume": "19", "author": [{"given": "M. L.", "family": "Rothenberg", "sequence": "first", "affiliation": []}, {"given": "J. V.", "family": "Cox", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Butts", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Navarro", "sequence": "additional", "affiliation": []}, {"given": "Y.-J.", "family": "Bang", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Goel", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Gollins", "sequence": "additional", "affiliation": []}, {"given": "L. L.", "family": "Siu", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Laguerre", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Cunningham", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2008, 6, 2]]}, "reference": [{"issue": "1", "key": "1_23507700", "doi-asserted-by": "publisher", "first-page": "38", "DOI": "10.1634/theoncologist.12-1-38", "volume": "12", "author": "Goldberg", "year": "2007", "journal-title": "The Oncologist", "ISSN": "http://id.crossref.org/issn/1083-7159", "issn-type": "print"}, {"issue": "21", "key": "2_11385471", "doi-asserted-by": "crossref", "first-page": "4097", "DOI": "10.1200/JCO.2001.19.21.4097", "volume": "19", "author": "Van Cutsem", "year": "2001", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "6", "key": "3_18091387", "doi-asserted-by": "publisher", "first-page": "1190", "DOI": "10.1038/sj.bjc.6601676", "volume": "90", "author": "Van Cutsem", "year": "2004", "journal-title": "British Journal of Cancer", "ISSN": "http://id.crossref.org/issn/0007-0920", "issn-type": "print"}, {"issue": "8", "key": "4_11113214", "doi-asserted-by": "crossref", "first-page": "2282", "DOI": "10.1200/JCO.2001.19.8.2282", "volume": "19", "author": "Hoff", "year": "2001", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "26", "key": "5_18958991", "doi-asserted-by": "publisher", "first-page": "2696", "DOI": "10.1056/NEJMoa043116", "volume": "352", "author": "Twelves", "year": "2005", "journal-title": "New England Journal of Medicine", "ISSN": "http://id.crossref.org/issn/0028-4793", "issn-type": "print"}, {"issue": "11", "key": "6_18202681", "doi-asserted-by": "publisher", "first-page": "2084", "DOI": "10.1200/JCO.2004.11.069", "volume": "22", "year": "2004", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "7", "key": "8_17559535", "doi-asserted-by": "publisher", "first-page": "1307", "DOI": "10.1200/JCO.2003.09.016", "volume": "21", "year": "2003", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"key": "9_28365490", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print", "volume": "24", "first-page": "18s", "year": "2006", "journal-title": "Journal of Clinical Oncology", "DOI": "10.1200/JCO.2006.06.1143", "doi-asserted-by": "crossref"}, {"issue": "18", "key": "10_23119446", "doi-asserted-by": "publisher", "first-page": "3161", "DOI": "10.1016/j.ejca.2006.08.034", "volume": "42", "author": "Martoni", "year": "2006", "journal-title": "European journal of cancer (Oxford, England : 1990)", "ISSN": "http://id.crossref.org/issn/0959-8049", "issn-type": "print"}, {"issue": "2", "key": "11_21103073", "doi-asserted-by": "publisher", "first-page": "252", "DOI": "10.1093/annonc/mdj060", "volume": "17", "year": "2006", "journal-title": "Annals of Oncology", "ISSN": "http://id.crossref.org/issn/0923-7534", "issn-type": "print"}, {"issue": "7", "key": "12_16980700", "doi-asserted-by": "publisher", "first-page": "1759", "DOI": "10.1200/JCO.2002.07.087", "volume": "20", "author": "Borner", "year": "2002", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "12", "key": "13_30810541", "doi-asserted-by": "publisher", "first-page": "2006", "DOI": "10.1200/JCO.2007.14.9898", "volume": "26", "author": "Cassidy", "year": "2008", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"key": "14_29091000", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print", "volume": "25", "first-page": "18s", "year": "2007", "journal-title": "Journal of Clinical Oncology"}, {"issue": "16", "key": "15_10436284", "doi-asserted-by": "crossref", "first-page": "2938", "DOI": "10.1200/JCO.2000.18.16.2938", "volume": "18", "author": "de Gramont", "year": "2000", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "3", "key": "16_6455034", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.1093/jnci/92.3.205", "volume": "92", "author": "Therasse", "year": "2000", "journal-title": "JNCI Journal of the National Cancer Institute", "ISSN": "http://id.crossref.org/issn/0027-8874", "issn-type": "print"}, {"issue": "2", "key": "17_17995196", "doi-asserted-by": "publisher", "first-page": "229", "DOI": "10.1200/JCO.2004.05.113", "volume": "22", "year": "2004", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "11", "key": "18_17650904", "doi-asserted-by": "publisher", "first-page": "2059", "DOI": "10.1200/JCO.2003.11.126", "volume": "21", "year": "2003", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}], "container-title": ["Annals of Oncology"], "language": "en", "link": [{"URL": "http://academic.oup.com/annonc/article-pdf/19/10/1720/661516/mdn370.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 12]], "date-time": "2019-02-12T03:44:11Z", "timestamp": 1549943051000}, "score": 47.93993, "issued": {"date-parts": [[2008, 6, 2]]}, "references-count": 17, "journal-issue": {"published-online": {"date-parts": [[2008, 6, 2]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.1093/annonc/mdn370", "relation": {"cites": []}, "ISSN": ["0923-7534", "1569-8041"], "issn-type": [{"value": "0923-7534", "type": "print"}, {"value": "1569-8041", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T23:16:46Z", "timestamp": 1574119006159}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 9, 1]], "date-time": "2003-09-01T00:00:00Z", "timestamp": 1062374400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer Supplements"], "published-print": {"date-parts": [[2003, 9]]}, "DOI": "10.1016/s1359-6349(03)90336-3", "type": "journal-article", "created": {"date-parts": [[2004, 4, 18]], "date-time": "2004-04-18T02:00:02Z", "timestamp": 1082253602000}, "page": "S93", "source": "Crossref", "is-referenced-by-count": 1, "title": ["303 Capecitabine plus oxaliplatin (XELOX): findings from a human colon cancer xenograft model and a phase II clinical trial in patients with metastatic colorectal cancer (MCRC)"], "prefix": "10.1016", "volume": "1", "author": [{"given": "N.", "family": "Sawada", "sequence": "first", "affiliation": []}, {"given": "Y.", "family": "Tanaka", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Twelves", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Tabernero", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Diaz-Rubio", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Van Cutsem", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1359634903903363?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1359634903903363?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 13]], "date-time": "2019-02-13T04:24:51Z", "timestamp": 1550031891000}, "score": 47.711765, "issued": {"date-parts": [[2003, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003, 9]]}, "issue": "5"}, "alternative-id": ["S1359634903903363"], "URL": "http://dx.doi.org/10.1016/s1359-6349(03)90336-3", "ISSN": ["1359-6349"], "issn-type": [{"value": "1359-6349", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T16:10:27Z", "timestamp": 1575216627276}, "reference-count": 28, "publisher": "SAGE Publications", "issue": "7", "license": [{"URL": "http://journals.sagepub.com/page/policies/text-and-data-mining-license", "start": {"date-parts": [[2005, 7, 1]], "date-time": "2005-07-01T00:00:00Z", "timestamp": 1120176000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hospital Pharmacy"], "published-print": {"date-parts": [[2005, 7]]}, "DOI": "10.1177/001857870504000704", "type": "journal-article", "created": {"date-parts": [[2017, 12, 27]], "date-time": "2017-12-27T22:20:05Z", "timestamp": 1514413205000}, "page": "564-569", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Capecitabine plus Oxaliplatin (XelOx/CapOx) Regimen for Colorectal Cancer"], "prefix": "10.1177", "volume": "40", "author": [{"given": "Parvaneh", "family": "Moussavian", "sequence": "first", "affiliation": [{"name": "Oncology Pharmacist, Hematology-Oncology Pharmacy Service, Department of Pharmacy, Walter Reed Army Medical Center, Washington, DC."}]}, {"suffix": "Jr.", "given": "Dominic A.", "family": "Solimando", "sequence": "additional", "affiliation": [{"name": "Oncology Pharmacy Services, Inc., 4201 Wilson Blvd #110-545, Arlington, VA 22203"}]}, {"given": "J. Aubrey", "family": "Waddell", "sequence": "additional", "affiliation": [{"name": "Oncology Pharmacy Residency Program, Department of Pharmacy, Walter Reed Army Medical Center, 6900 Georgia Avenue NW, Rm 2P02, Washington, DC 20307;"}]}], "member": "179", "published-online": {"date-parts": [[2017, 7, 20]]}, "reference": [{"issue": "11", "key": "bibr1-001857870504000704", "doi-asserted-by": "crossref", "first-page": "2084", "DOI": "10.1200/JCO.2004.11.069", "volume": "22", "author": "Cassidy J.", "year": "2004", "journal-title": "J Clin Oncol."}, {"issue": "3", "key": "bibr2-001857870504000704", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1002/cncr.11925", "volume": "100", "author": "Shields A.F.", "year": "2004", "journal-title": "Cancer."}, {"issue": "8", "key": "bibr3-001857870504000704", "doi-asserted-by": "crossref", "first-page": "832", "DOI": "10.1080/02841860310015894", "volume": "42", "author": "Pfeiffer P.", "year": "2003", "journal-title": "Acta Oncol."}, {"issue": "7", "key": "bibr4-001857870504000704", "doi-asserted-by": "crossref", "first-page": "1307", "DOI": "10.1200/JCO.2003.09.016", "volume": "21", "author": "Scheithauer W.", "year": "2003", "journal-title": "J Clin Oncol."}, {"issue": "5", "key": "bibr5-001857870504000704", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1016/S0936-6555(03)00019-0", "volume": "15", "author": "Sumpter K.", "year": "2003", "journal-title": "Clin Oncol (R Coll Radiol)."}, {"issue": "7", "key": "bibr6-001857870504000704", "doi-asserted-by": "crossref", "first-page": "1759", "DOI": "10.1200/JCO.2002.07.087", "volume": "20", "author": "Borner M.M.", "year": "2002", "journal-title": "J Clin Oncol."}, {"issue": "4", "key": "bibr7-001857870504000704", "doi-asserted-by": "crossref", "first-page": "558", "DOI": "10.1093/annonc/mdf065", "volume": "13", "author": "Diaz-Rubio E.", "year": "2002", "journal-title": "Ann Oncol."}, {"issue": "16", "key": "bibr8-001857870504000704", "doi-asserted-by": "crossref", "first-page": "3098", "DOI": "10.1200/JCO.2003.02.505", "volume": "21", "author": "R\u00f6del C.", "year": "2003", "journal-title": "J Clin Oncol."}, {"key": "bibr9-001857870504000704", "author": "Grothey A.", "volume": "22", "first-page": "255", "year": "2003", "journal-title": "Proc Am Soc Clin Oncol."}, {"key": "bibr10-001857870504000704", "author": "Jordan K.", "volume": "21", "year": "2002", "journal-title": "Proc Am Soc Clin Oncol."}, {"issue": "9", "key": "bibr11-001857870504000704", "doi-asserted-by": "crossref", "first-page": "1378", "DOI": "10.1093/annonc/mdg360", "volume": "14", "author": "Zeuli M.", "year": "2003", "journal-title": "Ann Oncol."}, {"issue": "10", "key": "bibr12-001857870504000704", "doi-asserted-by": "crossref", "first-page": "1583", "DOI": "10.1093/annonc/dkf281", "volume": "13", "author": "Scheithauer W.", "year": "2002", "journal-title": "Ann Oncol."}, {"issue": "1", "key": "bibr14-001857870504000704", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1200/JCO.1997.15.1.103", "volume": "15", "author": "Hesketh P.J.", "year": "1997", "journal-title": "J Clin Oncol."}, {"key": "bibr15-001857870504000704", "author": "Brandi G.", "volume": "89", "first-page": "477", "year": "2003", "journal-title": "Br J Cancer.", "DOI": "10.1038/sj.bjc.6601155", "doi-asserted-by": "crossref"}, {"key": "bibr16-001857870504000704", "author": "Qureshi K.M.", "volume": "22", "first-page": "789", "year": "2003", "journal-title": "Proc Am Soc Clin Oncol."}, {"key": "bibr17-001857870504000704", "author": "Dold F.", "volume": "21", "first-page": "370A", "year": "2002", "journal-title": "Proc Am Soc Clin Oncol."}, {"issue": "11", "key": "bibr18-001857870504000704", "first-page": "85", "volume": "9", "author": "Lyman G.H.", "year": "1995", "journal-title": "Oncology."}, {"issue": "13", "key": "bibr19-001857870504000704", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1016/S0093-7754(03)00312-9", "volume": "30", "author": "Lyman G.H.", "year": "2003", "journal-title": "Semin Oncol."}, {"issue": "20", "key": "bibr20-001857870504000704", "doi-asserted-by": "crossref", "first-page": "3558", "DOI": "10.1200/JCO.2000.18.20.3558", "volume": "18", "author": "Ozer H.", "year": "2000", "journal-title": "J Clin Oncol."}, {"key": "bibr21-001857870504000704", "author": "Kretzschmar A.", "volume": "21", "year": "2002", "journal-title": "Proc Am Soc Clin Oncol."}, {"key": "bibr22-001857870504000704", "author": "Benson A.B.", "volume": "22", "first-page": "2918", "year": "2004", "journal-title": "J Clin Oncol.", "DOI": "10.1200/JCO.2004.04.132", "doi-asserted-by": "crossref"}, {"issue": "15", "key": "bibr23-001857870504000704", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1053/sonc.2002.35525", "volume": "29", "author": "Gamelin E.", "year": "2002", "journal-title": "Semin Oncol."}, {"key": "bibr24-001857870504000704", "author": "Gamelin E.", "volume": "21", "first-page": "157A", "year": "2002", "journal-title": "Proc Am Soc Clin Oncol."}, {"issue": "14", "key": "bibr25-001857870504000704", "doi-asserted-by": "crossref", "first-page": "2664", "DOI": "10.1200/JCO.2003.11.015", "volume": "21", "author": "Takimoto C.H.", "year": "2003", "journal-title": "J Clin Oncol."}, {"key": "bibr26-001857870504000704", "year": "2003", "volume-title": "Xeloda [product information]."}, {"issue": "15", "key": "bibr27-001857870504000704", "doi-asserted-by": "crossref", "first-page": "14", "DOI": "10.1016/S0093-7754(03)00400-7", "volume": "30", "author": "Doroshow J.H.", "year": "2003", "journal-title": "Semin Oncol."}, {"issue": "3", "key": "bibr28-001857870504000704", "doi-asserted-by": "crossref", "first-page": "460", "DOI": "10.1093/annonc/mdh095", "volume": "15", "author": "Rubbia-Brandt L.", "year": "2004", "journal-title": "Ann Oncol."}, {"issue": "2", "key": "bibr29-001857870504000704", "doi-asserted-by": "crossref", "first-page": "162", "DOI": "10.1634/theoncologist.6-2-162", "volume": "6", "author": "King P.D.", "year": "2001", "journal-title": "Oncologist."}], "container-title": ["Hospital Pharmacy"], "language": "en", "link": [{"URL": "http://journals.sagepub.com/doi/pdf/10.1177/001857870504000704", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/pdf/10.1177/001857870504000704", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 12]], "date-time": "2018-07-12T11:31:32Z", "timestamp": 1531395092000}, "score": 46.564747, "issued": {"date-parts": [[2005, 7]]}, "references-count": 28, "journal-issue": {"published-online": {"date-parts": [[2017, 7, 20]]}, "published-print": {"date-parts": [[2005, 7]]}, "issue": "7"}, "alternative-id": ["10.1177/001857870504000704"], "URL": "http://dx.doi.org/10.1177/001857870504000704", "relation": {"cites": []}, "ISSN": ["0018-5787", "1945-1253"], "issn-type": [{"value": "0018-5787", "type": "print"}, {"value": "1945-1253", "type": "electronic"}], "subject": ["Pharmacology (medical)", "Pharmacology", "Pharmacy"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T19:30:34Z", "timestamp": 1574364634328}, "reference-count": 15, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2008, 4, 20]]}, "DOI": "10.1200/jco.2007.14.9898", "type": "journal-article", "created": {"date-parts": [[2008, 4, 17]], "date-time": "2008-04-17T22:28:58Z", "timestamp": 1208471338000}, "page": "2006-2012", "source": "Crossref", "is-referenced-by-count": 470, "title": ["Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer"], "prefix": "10.1200", "volume": "26", "author": [{"given": "Jim", "family": "Cassidy", "sequence": "first", "affiliation": [{"name": "From the Beatson Oncology Centre, Glasgow, United Kingdom; University of Sydney and Sydney Cancer Centre, Sydney, Australia; Hospital Cl\u00ednico San Carlos, Madrid; Hospital Marques De Valdecilla, Santander, Spain; Vienna University Medical School, Vienna, Austria; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Cancer Care Manitoba, St Boniface General Hospital, Winnipeg, Manitoba; Cross Cancer Institute, Edmonton, Alberta; CHUQ L'Hotel-Dieu De Quebec, Quebec, Canada; Russian Cancer Research Center,..."}]}, {"given": "Stephen", "family": "Clarke", "sequence": "additional", "affiliation": [{"name": "From the Beatson Oncology Centre, Glasgow, United Kingdom; University of Sydney and Sydney Cancer Centre, Sydney, Australia; Hospital Cl\u00ednico San Carlos, Madrid; Hospital Marques De Valdecilla, Santander, Spain; Vienna University Medical School, Vienna, Austria; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Cancer Care Manitoba, St Boniface General Hospital, Winnipeg, Manitoba; Cross Cancer Institute, Edmonton, Alberta; CHUQ L'Hotel-Dieu De Quebec, Quebec, Canada; Russian Cancer Research Center,..."}]}, {"given": "Eduardo", "family": "D\u00edaz-Rubio", "sequence": "additional", "affiliation": [{"name": "From the Beatson Oncology Centre, Glasgow, United Kingdom; University of Sydney and Sydney Cancer Centre, Sydney, Australia; Hospital Cl\u00ednico San Carlos, Madrid; Hospital Marques De Valdecilla, Santander, Spain; Vienna University Medical School, Vienna, Austria; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Cancer Care Manitoba, St Boniface General Hospital, Winnipeg, Manitoba; Cross Cancer Institute, Edmonton, Alberta; CHUQ L'Hotel-Dieu De Quebec, Quebec, Canada; Russian Cancer Research Center,..."}]}, {"given": "Werner", "family": "Scheithauer", "sequence": "additional", "affiliation": [{"name": "From the Beatson Oncology Centre, Glasgow, United Kingdom; University of Sydney and Sydney Cancer Centre, Sydney, Australia; Hospital Cl\u00ednico San Carlos, Madrid; Hospital Marques De Valdecilla, Santander, Spain; Vienna University Medical School, Vienna, Austria; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Cancer Care Manitoba, St Boniface General Hospital, Winnipeg, Manitoba; Cross Cancer Institute, Edmonton, Alberta; CHUQ L'Hotel-Dieu De Quebec, Quebec, Canada; Russian Cancer Research Center,..."}]}, {"given": "Arie", "family": "Figer", "sequence": "additional", "affiliation": [{"name": "From the Beatson Oncology Centre, Glasgow, United Kingdom; University of Sydney and Sydney Cancer Centre, Sydney, Australia; Hospital Cl\u00ednico San Carlos, Madrid; Hospital Marques De Valdecilla, Santander, Spain; Vienna University Medical School, Vienna, Austria; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Cancer Care Manitoba, St Boniface General Hospital, Winnipeg, Manitoba; Cross Cancer Institute, Edmonton, Alberta; CHUQ L'Hotel-Dieu De Quebec, Quebec, Canada; Russian Cancer Research Center,..."}]}, {"given": "Ralph", "family": "Wong", "sequence": "additional", "affiliation": [{"name": "From the Beatson Oncology Centre, Glasgow, United Kingdom; University of Sydney and Sydney Cancer Centre, Sydney, Australia; Hospital Cl\u00ednico San Carlos, Madrid; Hospital Marques De Valdecilla, Santander, Spain; Vienna University Medical School, Vienna, Austria; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Cancer Care Manitoba, St Boniface General Hospital, Winnipeg, Manitoba; Cross Cancer Institute, Edmonton, Alberta; CHUQ L'Hotel-Dieu De Quebec, Quebec, Canada; Russian Cancer Research Center,..."}]}, {"given": "Sheryl", "family": "Koski", "sequence": "additional", "affiliation": [{"name": "From the Beatson Oncology Centre, Glasgow, United Kingdom; University of Sydney and Sydney Cancer Centre, Sydney, Australia; Hospital Cl\u00ednico San Carlos, Madrid; Hospital Marques De Valdecilla, Santander, Spain; Vienna University Medical School, Vienna, Austria; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Cancer Care Manitoba, St Boniface General Hospital, Winnipeg, Manitoba; Cross Cancer Institute, Edmonton, Alberta; CHUQ L'Hotel-Dieu De Quebec, Quebec, Canada; Russian Cancer Research Center,..."}]}, {"given": "Mikhail", "family": "Lichinitser", "sequence": "additional", "affiliation": [{"name": "From the Beatson Oncology Centre, Glasgow, United Kingdom; University of Sydney and Sydney Cancer Centre, Sydney, Australia; Hospital Cl\u00ednico San Carlos, Madrid; Hospital Marques De Valdecilla, Santander, Spain; Vienna University Medical School, Vienna, Austria; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Cancer Care Manitoba, St Boniface General Hospital, Winnipeg, Manitoba; Cross Cancer Institute, Edmonton, Alberta; CHUQ L'Hotel-Dieu De Quebec, Quebec, Canada; Russian Cancer Research Center,..."}]}, {"given": "Tsai-Shen", "family": "Yang", "sequence": "additional", "affiliation": [{"name": "From the Beatson Oncology Centre, Glasgow, United Kingdom; University of Sydney and Sydney Cancer Centre, Sydney, Australia; Hospital Cl\u00ednico San Carlos, Madrid; Hospital Marques De Valdecilla, Santander, Spain; Vienna University Medical School, Vienna, Austria; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Cancer Care Manitoba, St Boniface General Hospital, Winnipeg, Manitoba; Cross Cancer Institute, Edmonton, Alberta; CHUQ L'Hotel-Dieu De Quebec, Quebec, Canada; Russian Cancer Research Center,..."}]}, {"given": "Fernando", "family": "Rivera", "sequence": "additional", "affiliation": [{"name": "From the Beatson Oncology Centre, Glasgow, United Kingdom; University of Sydney and Sydney Cancer Centre, Sydney, Australia; Hospital Cl\u00ednico San Carlos, Madrid; Hospital Marques De Valdecilla, Santander, Spain; Vienna University Medical School, Vienna, Austria; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Cancer Care Manitoba, St Boniface General Hospital, Winnipeg, Manitoba; Cross Cancer Institute, Edmonton, Alberta; CHUQ L'Hotel-Dieu De Quebec, Quebec, Canada; Russian Cancer Research Center,..."}]}, {"given": "Felix", "family": "Couture", "sequence": "additional", "affiliation": [{"name": "From the Beatson Oncology Centre, Glasgow, United Kingdom; University of Sydney and Sydney Cancer Centre, Sydney, Australia; Hospital Cl\u00ednico San Carlos, Madrid; Hospital Marques De Valdecilla, Santander, Spain; Vienna University Medical School, Vienna, Austria; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Cancer Care Manitoba, St Boniface General Hospital, Winnipeg, Manitoba; Cross Cancer Institute, Edmonton, Alberta; CHUQ L'Hotel-Dieu De Quebec, Quebec, Canada; Russian Cancer Research Center,..."}]}, {"given": "Florin", "family": "Sirz\u00e9n", "sequence": "additional", "affiliation": [{"name": "From the Beatson Oncology Centre, Glasgow, United Kingdom; University of Sydney and Sydney Cancer Centre, Sydney, Australia; Hospital Cl\u00ednico San Carlos, Madrid; Hospital Marques De Valdecilla, Santander, Spain; Vienna University Medical School, Vienna, Austria; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Cancer Care Manitoba, St Boniface General Hospital, Winnipeg, Manitoba; Cross Cancer Institute, Edmonton, Alberta; CHUQ L'Hotel-Dieu De Quebec, Quebec, Canada; Russian Cancer Research Center,..."}]}, {"given": "Leonard", "family": "Saltz", "sequence": "additional", "affiliation": [{"name": "From the Beatson Oncology Centre, Glasgow, United Kingdom; University of Sydney and Sydney Cancer Centre, Sydney, Australia; Hospital Cl\u00ednico San Carlos, Madrid; Hospital Marques De Valdecilla, Santander, Spain; Vienna University Medical School, Vienna, Austria; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Cancer Care Manitoba, St Boniface General Hospital, Winnipeg, Manitoba; Cross Cancer Institute, Edmonton, Alberta; CHUQ L'Hotel-Dieu De Quebec, Quebec, Canada; Russian Cancer Research Center,..."}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdf/10.1200/JCO.2007.14.9898", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 10]], "date-time": "2019-05-10T13:19:23Z", "timestamp": 1557494363000}, "score": 46.097786, "issued": {"date-parts": [[2008, 4, 20]]}, "references-count": 15, "journal-issue": {"published-print": {"date-parts": [[2008, 4, 20]]}, "issue": "12"}, "alternative-id": ["10.1200/JCO.2007.14.9898"], "URL": "http://dx.doi.org/10.1200/jco.2007.14.9898", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T16:59:13Z", "timestamp": 1575305953409}, "reference-count": 42, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2005, 7, 1]], "date-time": "2005-07-01T00:00:00Z", "timestamp": 1120176000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Colorectal Cancer"], "published-print": {"date-parts": [[2005, 7]]}, "DOI": "10.3816/ccc.2005.n.021", "type": "journal-article", "created": {"date-parts": [[2008, 9, 11]], "date-time": "2008-09-11T01:05:58Z", "timestamp": 1221095158000}, "page": "101-107", "source": "Crossref", "is-referenced-by-count": 39, "title": ["Capecitabine/Oxaliplatin, a Safe and Active First-Line Regimen for Older Patients Metastatic Colorectal Cancer: Post Hoc Analysis of a Large Phase II Study"], "prefix": "10.3816", "volume": "5", "author": [{"given": "Chris J.", "family": "Twelves", "sequence": "first", "affiliation": []}, {"given": "Charles A.", "family": "Butts", "sequence": "additional", "affiliation": []}, {"given": "Jim", "family": "Cassidy", "sequence": "additional", "affiliation": []}, {"given": "Thierry", "family": "Conroy", "sequence": "additional", "affiliation": []}, {"given": "Filippo", "family": "de Braud", "sequence": "additional", "affiliation": []}, {"given": "Eduardo", "family": "D\u00edaz-Rubio", "sequence": "additional", "affiliation": []}, {"given": "Josep M.", "family": "Tabernero", "sequence": "additional", "affiliation": []}, {"given": "Patrick", "family": "Sch\u00f6ffski", "sequence": "additional", "affiliation": []}, {"given": "Arie", "family": "Figer", "sequence": "additional", "affiliation": []}, {"given": "Ren\u00e9", "family": "Brunet", "sequence": "additional", "affiliation": []}, {"given": "Johannes", "family": "Grossmann", "sequence": "additional", "affiliation": []}, {"given": "Alberto F.", "family": "Sobrero", "sequence": "additional", "affiliation": []}, {"given": "Eric J.", "family": "Van Cutsem", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Clinical Colorectal Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1533002811701724?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1533002811701724?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 25]], "date-time": "2018-12-25T23:25:24Z", "timestamp": 1545780324000}, "score": 45.74667, "issued": {"date-parts": [[2005, 7]]}, "references-count": 42, "journal-issue": {"published-print": {"date-parts": [[2005, 7]]}, "issue": "2"}, "alternative-id": ["S1533002811701724"], "URL": "http://dx.doi.org/10.3816/ccc.2005.n.021", "ISSN": ["1533-0028"], "issn-type": [{"value": "1533-0028", "type": "print"}], "subject": ["Gastroenterology", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T00:00:12Z", "timestamp": 1576800012256}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "15_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2010, 5, 20]]}, "DOI": "10.1200/jco.2010.28.15_suppl.e13567", "type": "journal-article", "created": {"date-parts": [[2017, 2, 24]], "date-time": "2017-02-24T02:41:10Z", "timestamp": 1487904070000}, "page": "e13567-e13567", "source": "Crossref", "is-referenced-by-count": 0, "title": ["A phase Ib pharmacokinetic (PK) study of CKD-732 plus capecitabine and oxaliplatin (XELOX) in patients with metastatic colorectal cancer (mCRC) treated with prior irinotecan-based chemotherapy."], "prefix": "10.1200", "volume": "28", "author": [{"given": "S. J.", "family": "Shin", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Ahn", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Hong", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Jeung", "sequence": "additional", "affiliation": []}, {"given": "S. Y.", "family": "Rha", "sequence": "additional", "affiliation": []}, {"given": "J. K.", "family": "Roh", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Chung", "sequence": "additional", "affiliation": []}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2010.28.15_suppl.e13567", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T22:15:56Z", "timestamp": 1574892956000}, "score": 45.344696, "issued": {"date-parts": [[2010, 5, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 5, 20]]}, "issue": "15_suppl"}, "alternative-id": ["10.1200/jco.2010.28.15_suppl.e13567"], "URL": "http://dx.doi.org/10.1200/jco.2010.28.15_suppl.e13567", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:59:31Z", "timestamp": 1576799971965}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "15_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2010, 5, 20]]}, "DOI": "10.1200/jco.2010.28.15_suppl.3539", "type": "journal-article", "created": {"date-parts": [[2017, 2, 24]], "date-time": "2017-02-24T02:41:10Z", "timestamp": 1487904070000}, "page": "3539-3539", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Phase II study of bevacizumab (B) plus oxaliplatin (Ox) plus capecitabine (C) followed by bevacizumab (B) plus erlotinib (E) as first-line treatment in metastatic colorectal cancer (mCRC)."], "prefix": "10.1200", "volume": "28", "author": [{"given": "A.", "family": "Mu\u00f1oz", "sequence": "first", "affiliation": []}, {"given": "C.", "family": "Pericay", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Llorente", "sequence": "additional", "affiliation": []}, {"given": "V.", "family": "Alonso", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Due\u00f1as", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Roca", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Rivera", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Falco", "sequence": "additional", "affiliation": []}, {"given": "I.", "family": "Alvarez", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Salud", "sequence": "additional", "affiliation": []}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2010.28.15_suppl.3539", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:18:52Z", "timestamp": 1574889532000}, "score": 44.561245, "issued": {"date-parts": [[2010, 5, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 5, 20]]}, "issue": "15_suppl"}, "alternative-id": ["10.1200/jco.2010.28.15_suppl.3539"], "URL": "http://dx.doi.org/10.1200/jco.2010.28.15_suppl.3539", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T04:45:33Z", "timestamp": 1574484333711}, "reference-count": 6, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2010, 12, 14]], "date-time": "2010-12-14T00:00:00Z", "timestamp": 1292284800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[2011, 1]]}, "DOI": "10.1038/sj.bjc.6606043", "type": "journal-article", "created": {"date-parts": [[2010, 12, 14]], "date-time": "2010-12-14T21:06:34Z", "timestamp": 1292360794000}, "page": "226-226", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Reply: Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer"], "prefix": "10.1038", "volume": "104", "author": [{"given": "J", "family": "Feliu", "sequence": "first", "affiliation": []}, {"given": "J", "family": "Barriuso", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 12, 14]]}, "reference": [{"key": "BF6606043_CR1", "doi-asserted-by": "publisher", "first-page": "224", "DOI": "10.1634/theoncologist.5-3-224", "volume": "5", "author": "L Balducci", "year": "2000", "unstructured": "Balducci L, Extreman M (2000) Management of cancer in the older person: a practical approach. Oncologist 5: 224\u2013237", "journal-title": "Oncologist"}, {"key": "BF6606043_CR2", "doi-asserted-by": "publisher", "first-page": "380", "DOI": "10.1016/j.ctrv.2005.04.012", "volume": "31", "author": "I Carreca", "year": "2005", "unstructured": "Carreca I, Balducci L, Extreman M (2005) Cancer in the older person. Cancer Treat Rev 31: 380\u2013402", "journal-title": "Cancer Treat Rev"}, {"key": "BF6606043_CR3", "doi-asserted-by": "publisher", "first-page": "790", "DOI": "10.1016/S1470-2045(05)70389-2", "volume": "6", "author": "MA Gosney", "year": "2005", "unstructured": "Gosney MA (2005) Clinical assessment of elderly people with cancer. Lancet Oncol 6: 790\u2013797", "journal-title": "Lancet Oncol"}, {"key": "BF6606043_CR4", "doi-asserted-by": "publisher", "first-page": "390", "DOI": "10.1634/theoncologist.2007-0043", "volume": "13", "author": "CH K\u00f6hne", "year": "2008", "unstructured": "K\u00f6hne CH, Folprecht G, Goldberg RM, Mitry E, Rougier P (2008) Chemotherapy in elderly patients with colorectal cancer. Oncologist 13: 390\u2013402", "journal-title": "Oncologist"}, {"key": "BF6606043_CR5", "unstructured": "Molina-Garrido MJ, Guill\u00e9n-Ponce C (2010) Comment on \u2018Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer\u2019. Br J Cancer, e-pub ahead of print 14 December 2010; doi:10.1038/sj.bjc.6606037", "DOI": "10.1038/sj.bjc.6606037", "doi-asserted-by": "crossref"}, {"key": "BF6606043_CR6", "doi-asserted-by": "publisher", "first-page": "149", "DOI": "10.1053/j.seminoncol.2003.12.026", "volume": "31", "author": "AV Rao", "year": "2004", "unstructured": "Rao AV, Seo PH, Cohen HJ (2004) Geriatric assessment and comorbility. Semin Oncol 31: 149\u2013159", "journal-title": "Semin Oncol"}], "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/6606043.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6606043", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6606043.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 15]], "date-time": "2019-05-15T06:09:55Z", "timestamp": 1557900595000}, "score": 44.179844, "issued": {"date-parts": [[2010, 12, 14]]}, "references-count": 6, "journal-issue": {"published-print": {"date-parts": [[2011, 1]]}, "issue": "1"}, "alternative-id": ["BF6606043"], "URL": "http://dx.doi.org/10.1038/sj.bjc.6606043", "relation": {"cites": []}, "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:54:57Z", "timestamp": 1576799697129}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "14_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2004, 7, 15]]}, "DOI": "10.1200/jco.2004.22.14_suppl.3688", "type": "journal-article", "created": {"date-parts": [[2017, 4, 5]], "date-time": "2017-04-05T08:02:15Z", "timestamp": 1491379335000}, "page": "3688-3688", "source": "Crossref", "is-referenced-by-count": 1, "title": ["XELOX (capecitabine and oxaliplatin) as 1st line treatment for elderly patients (pts) with advanced/metastatic colorectal cancer (MCRC)"], "prefix": "10.1200", "volume": "22", "author": [{"given": "L.", "family": "L\u00f3pez-G\u00f3mez", "sequence": "first", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "P.", "family": "Escudero", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "A.", "family": "Yubero", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "J.", "family": "Feli\u00fa", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "A.", "family": "Salud", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "A.", "family": "Gal\u00e1n", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "M.", "family": "Bola\u00f1os", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "J. M.", "family": "Vicent", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "F.", "family": "Losa", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "M.", "family": "Gonz\u00e1lez-Bar\u00f3n", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.14_suppl.3688", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:55:12Z", "timestamp": 1574891712000}, "score": 43.965405, "issued": {"date-parts": [[2004, 7, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 7, 15]]}, "issue": "14_suppl"}, "alternative-id": ["10.1200/jco.2004.22.14_suppl.3688"], "URL": "http://dx.doi.org/10.1200/jco.2004.22.14_suppl.3688", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:56:01Z", "timestamp": 1576799761369}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "14_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2004, 7, 15]]}, "DOI": "10.1200/jco.2004.22.90140.3688", "type": "journal-article", "created": {"date-parts": [[2017, 4, 5]], "date-time": "2017-04-05T07:17:42Z", "timestamp": 1491376662000}, "page": "3688-3688", "source": "Crossref", "is-referenced-by-count": 0, "title": ["XELOX (capecitabine and oxaliplatin) as 1st line treatment for elderly patients (pts) with advanced/metastatic colorectal cancer (MCRC)"], "prefix": "10.1200", "volume": "22", "author": [{"given": "L.", "family": "L\u00f3pez-G\u00f3mez", "sequence": "first", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "P.", "family": "Escudero", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "A.", "family": "Yubero", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "J.", "family": "Feli\u00fa", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "A.", "family": "Salud", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "A.", "family": "Gal\u00e1n", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "M.", "family": "Bola\u00f1os", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "J. M.", "family": "Vicent", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "F.", "family": "Losa", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}, {"given": "M.", "family": "Gonz\u00e1lez-Bar\u00f3n", "sequence": "additional", "affiliation": [{"name": "Hospital Virgen de la Salud, Toledo, Spain; Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain; Hospital Obispo Polanco, Teruel, Spain; Hospital La Paz, Madrid, Spain; Hospital Arnau de Villanova, Lleida, Spain; Hospital de Sagunto, Valencia, Spain; Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hospital General Universitario de Valencia, Valencia, Spain; Hospital de la Creu Roja, Barcelona, Spain"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.90140.3688", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T22:22:57Z", "timestamp": 1574893377000}, "score": 43.965405, "issued": {"date-parts": [[2004, 7, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 7, 15]]}, "issue": "14_suppl"}, "alternative-id": ["10.1200/jco.2004.22.90140.3688"], "URL": "http://dx.doi.org/10.1200/jco.2004.22.90140.3688", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:57:07Z", "timestamp": 1576799827480}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "16_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2005, 6]]}, "DOI": "10.1200/jco.2005.23.16_suppl.3620", "type": "journal-article", "created": {"date-parts": [[2017, 2, 23]], "date-time": "2017-02-23T18:55:09Z", "timestamp": 1487876109000}, "page": "3620-3620", "source": "Crossref", "is-referenced-by-count": 0, "title": ["XELOX (capecitabine and oxaliplatin) as 1st line treatment for elderly patients (pts) with advanced/metastatic colorectal cancer (MCRC)"], "prefix": "10.1200", "volume": "23", "author": [{"given": "A.", "family": "Salud", "sequence": "first", "affiliation": [{"name": "Hosp Arnau de Vilanova, Lleida, Spain; Hosp Lozano Blesa, Zaragoza, Spain; Hosp La Paz, Madrid, Spain; Hosp Virgen de la Salud, Toledo, Spain; Hosp San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hosp de Sagunto, Valencia, Spain; Hosp Obispo Polanco, Teruel, Spain; Hosp Gen Univ de Valencia, Valencia, Spain; Hosp de la Creu Roja, Barcelona, Spain"}]}, {"given": "P.", "family": "Escudero", "sequence": "additional", "affiliation": [{"name": "Hosp Arnau de Vilanova, Lleida, Spain; Hosp Lozano Blesa, Zaragoza, Spain; Hosp La Paz, Madrid, Spain; Hosp Virgen de la Salud, Toledo, Spain; Hosp San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hosp de Sagunto, Valencia, Spain; Hosp Obispo Polanco, Teruel, Spain; Hosp Gen Univ de Valencia, Valencia, Spain; Hosp de la Creu Roja, Barcelona, Spain"}]}, {"given": "J.", "family": "Feli\u00fa", "sequence": "additional", "affiliation": [{"name": "Hosp Arnau de Vilanova, Lleida, Spain; Hosp Lozano Blesa, Zaragoza, Spain; Hosp La Paz, Madrid, Spain; Hosp Virgen de la Salud, Toledo, Spain; Hosp San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hosp de Sagunto, Valencia, Spain; Hosp Obispo Polanco, Teruel, Spain; Hosp Gen Univ de Valencia, Valencia, Spain; Hosp de la Creu Roja, Barcelona, Spain"}]}, {"given": "L.", "family": "L\u00f3pez-G\u00f3mez", "sequence": "additional", "affiliation": [{"name": "Hosp Arnau de Vilanova, Lleida, Spain; Hosp Lozano Blesa, Zaragoza, Spain; Hosp La Paz, Madrid, Spain; Hosp Virgen de la Salud, Toledo, Spain; Hosp San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hosp de Sagunto, Valencia, Spain; Hosp Obispo Polanco, Teruel, Spain; Hosp Gen Univ de Valencia, Valencia, Spain; Hosp de la Creu Roja, Barcelona, Spain"}]}, {"given": "M.", "family": "Bola\u00f1os", "sequence": "additional", "affiliation": [{"name": "Hosp Arnau de Vilanova, Lleida, Spain; Hosp Lozano Blesa, Zaragoza, Spain; Hosp La Paz, Madrid, Spain; Hosp Virgen de la Salud, Toledo, Spain; Hosp San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hosp de Sagunto, Valencia, Spain; Hosp Obispo Polanco, Teruel, Spain; Hosp Gen Univ de Valencia, Valencia, Spain; Hosp de la Creu Roja, Barcelona, Spain"}]}, {"given": "A.", "family": "Gal\u00e1n", "sequence": "additional", "affiliation": [{"name": "Hosp Arnau de Vilanova, Lleida, Spain; Hosp Lozano Blesa, Zaragoza, Spain; Hosp La Paz, Madrid, Spain; Hosp Virgen de la Salud, Toledo, Spain; Hosp San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hosp de Sagunto, Valencia, Spain; Hosp Obispo Polanco, Teruel, Spain; Hosp Gen Univ de Valencia, Valencia, Spain; Hosp de la Creu Roja, Barcelona, Spain"}]}, {"given": "A.", "family": "Yubero", "sequence": "additional", "affiliation": [{"name": "Hosp Arnau de Vilanova, Lleida, Spain; Hosp Lozano Blesa, Zaragoza, Spain; Hosp La Paz, Madrid, Spain; Hosp Virgen de la Salud, Toledo, Spain; Hosp San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hosp de Sagunto, Valencia, Spain; Hosp Obispo Polanco, Teruel, Spain; Hosp Gen Univ de Valencia, Valencia, Spain; Hosp de la Creu Roja, Barcelona, Spain"}]}, {"given": "J. M.", "family": "Vicent", "sequence": "additional", "affiliation": [{"name": "Hosp Arnau de Vilanova, Lleida, Spain; Hosp Lozano Blesa, Zaragoza, Spain; Hosp La Paz, Madrid, Spain; Hosp Virgen de la Salud, Toledo, Spain; Hosp San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hosp de Sagunto, Valencia, Spain; Hosp Obispo Polanco, Teruel, Spain; Hosp Gen Univ de Valencia, Valencia, Spain; Hosp de la Creu Roja, Barcelona, Spain"}]}, {"given": "F.", "family": "Losa", "sequence": "additional", "affiliation": [{"name": "Hosp Arnau de Vilanova, Lleida, Spain; Hosp Lozano Blesa, Zaragoza, Spain; Hosp La Paz, Madrid, Spain; Hosp Virgen de la Salud, Toledo, Spain; Hosp San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hosp de Sagunto, Valencia, Spain; Hosp Obispo Polanco, Teruel, Spain; Hosp Gen Univ de Valencia, Valencia, Spain; Hosp de la Creu Roja, Barcelona, Spain"}]}, {"given": "M.", "family": "Gonz\u00e1lez Bar\u00f3n", "sequence": "additional", "affiliation": [{"name": "Hosp Arnau de Vilanova, Lleida, Spain; Hosp Lozano Blesa, Zaragoza, Spain; Hosp La Paz, Madrid, Spain; Hosp Virgen de la Salud, Toledo, Spain; Hosp San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain; Hosp de Sagunto, Valencia, Spain; Hosp Obispo Polanco, Teruel, Spain; Hosp Gen Univ de Valencia, Valencia, Spain; Hosp de la Creu Roja, Barcelona, Spain"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2005.23.16_suppl.3620", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:17:22Z", "timestamp": 1574889442000}, "score": 43.965405, "issued": {"date-parts": [[2005, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 6]]}, "issue": "16_suppl"}, "alternative-id": ["10.1200/jco.2005.23.16_suppl.3620"], "URL": "http://dx.doi.org/10.1200/jco.2005.23.16_suppl.3620", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T05:16:33Z", "timestamp": 1574745393726}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "suppl_6", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016, 10]]}, "DOI": "10.1093/annonc/mdw370.44", "type": "journal-article", "created": {"date-parts": [[2017, 2, 3]], "date-time": "2017-02-03T17:33:47Z", "timestamp": 1486143227000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["A triplet combination with oxaliplatin/capecitabine/irinotecan (XELOXIRI) plus cetuximab (Cmab) as a first-line therapy in wild-type KRAS, metastatic colorectal cancer: a dose escalating study"], "prefix": "10.1093", "volume": "27", "author": [{"given": "Y.", "family": "Sato", "sequence": "first", "affiliation": []}, {"given": "H.", "family": "Ohnuma", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Hirakawa", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Kikuch", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Takahashi", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Okamoto", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Tsuji", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Okita", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Furuhata", "sequence": "additional", "affiliation": []}, {"given": "I.", "family": "Takemasa", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Kato", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2016, 10, 11]]}, "container-title": ["Annals of Oncology"], "language": "en", "link": [{"URL": "http://academic.oup.com/annonc/article-pdf/27/suppl_6/496P/19450112/mdw370.44.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 9]], "date-time": "2017-08-09T05:31:57Z", "timestamp": 1502256717000}, "score": 43.509697, "issued": {"date-parts": [[2016, 10]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 10, 11]]}, "published-print": {"date-parts": [[2016, 10]]}, "issue": "suppl_6"}, "URL": "http://dx.doi.org/10.1093/annonc/mdw370.44", "ISSN": ["0923-7534", "1569-8041"], "issn-type": [{"value": "0923-7534", "type": "print"}, {"value": "1569-8041", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T19:31:18Z", "timestamp": 1574451078465}, "reference-count": 19, "publisher": "Springer Science and Business Media LLC", "issue": "5", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2010, 7, 30]], "date-time": "2010-07-30T00:00:00Z", "timestamp": 1280448000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Chemother Pharmacol"], "published-print": {"date-parts": [[2011, 5]]}, "DOI": "10.1007/s00280-010-1322-0", "type": "journal-article", "created": {"date-parts": [[2010, 7, 29]], "date-time": "2010-07-29T10:18:05Z", "timestamp": 1280398685000}, "page": "1111-1117", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study"], "prefix": "10.1007", "volume": "67", "author": [{"given": "T.", "family": "Waddell", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Gollins", "sequence": "additional", "affiliation": []}, {"given": "W.", "family": "Soe", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Valle", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Allen", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Bentley", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Morris", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Lloyd", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Swindell", "sequence": "additional", "affiliation": []}, {"given": "M. B.", "family": "Taylor", "sequence": "additional", "affiliation": []}, {"given": "M. P.", "family": "Saunders", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 7, 30]]}, "reference": [{"key": "1322_CR1", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1016/S0140-6736(03)12461-0", "volume": "361", "author": "TS Maughan", "year": "2003", "unstructured": "Maughan TS, James RD, Kerr DJ, Ledermann JA, Seymour MT, Topham C, McArdle C, Cain D, Stephens RJ, Medical Research Council Colorectal Cancer Group (2003) Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial. Lancet 361:457\u2013464", "journal-title": "Lancet"}, {"key": "1322_CR2", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1200/JCO.2004.09.046", "volume": "22", "author": "RM Goldberg", "year": "2004", "unstructured": "Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts SR (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23\u201330", "journal-title": "J Clin Oncol"}, {"key": "1322_CR3", "doi-asserted-by": "crossref", "first-page": "3347", "DOI": "10.1200/JCO.2006.06.1317", "volume": "24", "author": "RM Goldberg", "year": "2006", "unstructured": "Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts S (2006) Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial. J Clin Oncol 24:3347\u20133353", "journal-title": "J Clin Oncol"}, {"key": "1322_CR4", "doi-asserted-by": "crossref", "first-page": "2938", "DOI": "10.1200/JCO.2000.18.16.2938", "volume": "18", "author": "A Gramont de", "year": "2000", "unstructured": "de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938\u20132947", "journal-title": "J Clin Oncol"}, {"key": "1322_CR5", "doi-asserted-by": "crossref", "first-page": "2006", "DOI": "10.1200/JCO.2007.14.9898", "volume": "26", "author": "J Cassidy", "year": "2008", "unstructured": "Cassidy J, Clarke S, D\u00edaz-Rubio E, Scheithauer W, Figer A, Wong R, Koski S, Lichinitser M, Yang TS, Rivera F, Couture F, Sirz\u00e9n F, Saltz L (2008) Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol 26:2006\u20132012", "journal-title": "J Clin Oncol"}, {"key": "1322_CR6", "doi-asserted-by": "crossref", "first-page": "4224", "DOI": "10.1200/JCO.2006.09.8467", "volume": "25", "author": "E D\u00edaz-Rubio", "year": "2007", "unstructured": "D\u00edaz-Rubio E, Tabernero J, G\u00f3mez-Espa\u00f1a A, Massut\u00ed B, Sastre J, Chaves M, Abad A, Carrato A, Queralt B, Reina JJ, Maurel J, Gonz\u00e1lez-Flores E, Aparicio J, Rivera F, Losa F, Aranda E, Spanish Cooperative Group for the Treatment of Digestive Tumors Trial (2007) Phase III trial of capecitabine and oxaliplatin (XELOX) vs continuous infusion 5-fluorouracil plus oxaliplatin (FUOX) as first-line therapy in metastatic colorectal cancer: final report of the Spanish TTD group trial. J Clin Oncol 25:4224\u20134230", "journal-title": "J Clin Oncol"}, {"key": "1322_CR7", "unstructured": "Ducreux M, Bennouna J, Hebbar M, Ychou M, Lledo G, Conroy T, Adenis A, Faroux R, Rebischung C, Douillard J (2007) Efficacy and safety findings from a randomized phase III study of capecitabine (X)\u00a0+\u00a0oxaliplatin (O) (XELOX) vs. infusional 5- FU/LV\u00a0+\u00a0O (FOLFOX-6) for metastatic colorectal cancer (MCRC). J Clin Oncol 25;18S (suppl abstract 4029)"}, {"key": "1322_CR8", "doi-asserted-by": "crossref", "first-page": "136", "DOI": "10.1200/JCO.2000.18.1.136", "volume": "18", "author": "S Giacchetti", "year": "2000", "unstructured": "Giacchetti S, Perpoint B, Zidani R, Le Bail N, Faggiuolo R, Focan C, Chollet P, Llory JF, Letourneau Y, Coudert B, Bertheaut-Cvitkovic F, Larregain-Fournier D, Le Rol A, Walter S, Adam R, Misset JL, L\u00e9vi F (2000) Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18:136\u2013147", "journal-title": "J Clin Oncol"}, {"key": "1322_CR9", "doi-asserted-by": "crossref", "first-page": "394", "DOI": "10.1200/JCO.2005.03.0106", "volume": "24", "author": "C Tournigand", "year": "2006", "unstructured": "Tournigand C, Cervantes A, Figer A, Lledo G, Flesch M, Buyse M, Mineur L, Carola E, Etienne PL, Rivera F, Chirivella I, Perez-Staub N, Louvet C, Andr\u00e9 T, Tabah-Fisch I, de Gramont A (2006) OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer: a GERCOR study. J Clin Oncol 24:394\u2013400", "journal-title": "J Clin Oncol"}, {"key": "1322_CR10", "unstructured": "Maindrault-Goebel F, Lledo G, Chibaudel B, Mineur L, Andre T, Bennamoun M, Mabro M, Artru P, Louvet C, De Gramont A (2006) OPTIMOX2, a large randomized phase II study of maintenance therapy or chemotherapy-free intervals (CFI) after FOLFOX in patients with metastatic colorectal cancer (MRC): a GERCOR study. J Clin Oncol 24 (18S; abstract 3504)"}, {"key": "1322_CR11", "unstructured": "Labianca R, Floriani I, Cortesi E, Isa L, Zaniboni A, Marangolo M, Frontini L, Barni S, Beretta GD, Sobrero A, Italian Group for the Study of Digestive Tract Cancers (2006) Alternating versus continuous \u201cFOLFIRI\u201d in advanced colorectal cancer (ACC): A randomized \u201cGISCAD\u201d trial J Clin Oncol 24 (18S; abstract 3505)"}, {"key": "1322_CR12", "doi-asserted-by": "crossref", "first-page": "2282", "DOI": "10.1200/JCO.2001.19.8.2282", "volume": "19", "author": "PM Hoff", "year": "2001", "unstructured": "Hoff PM, Ansari R, Batist G, Cox J, Kocha W, Kuperminc M, Maroun J, Walde D, Weaver C, Harrison E, Burger HU, Osterwalder B, Wong AO, Wong R (2001) Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 19:2282\u20132292", "journal-title": "J Clin Oncol"}, {"key": "1322_CR13", "doi-asserted-by": "crossref", "first-page": "4097", "DOI": "10.1200/JCO.2001.19.21.4097", "volume": "19", "author": "E Cutsem Van", "year": "2001", "unstructured": "Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, Bugat R, Findlay M, Frings S, Jahn M, McKendrick J, Osterwalder B, Perez-Manga G, Rosso R, Rougier P, Schmiegel WH, Seitz JF, Thompson P, Vieitez JM, Weitzel C, Harper P, Xeloda Colorectal Cancer Study Group (2001) Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19:4097\u20134106", "journal-title": "J Clin Oncol"}, {"key": "1322_CR14", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1093/jnci/92.3.205", "volume": "92", "author": "P Therasse", "year": "2000", "unstructured": "Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205\u2013216", "journal-title": "J Natl Cancer Inst"}, {"key": "1322_CR15", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.1093/jnci/85.5.365", "volume": "85", "author": "NK Aaronson", "year": "1993", "unstructured": "Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365\u2013376", "journal-title": "J Natl Cancer Inst"}, {"key": "1322_CR16", "doi-asserted-by": "crossref", "first-page": "238", "DOI": "10.1016/S0959-8049(98)00357-8", "volume": "35", "author": "MA Sprangers", "year": "1999", "unstructured": "Sprangers MA, te Velde A, Aaronson NK (1999) The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer 35:238\u2013247", "journal-title": "Eur J Cancer"}, {"key": "1322_CR17", "doi-asserted-by": "crossref", "first-page": "1413", "DOI": "10.1016/S0140-6736(98)02309-5", "volume": "352", "author": "D Cunningham", "year": "1998", "unstructured": "Cunningham D, Pyrhonen S, James RD, Punt CJ, Hickish TF, Heikkila R, Johannesen TB, Starkhammar H, Topham CA, Awad L, Jacques C, Herait P (1998) Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 352:1413\u20131418", "journal-title": "Lancet"}, {"key": "1322_CR18", "doi-asserted-by": "crossref", "first-page": "4574", "DOI": "10.1200/JCO.2002.08.535", "volume": "20", "author": "TJ Hobday", "year": "2002", "unstructured": "Hobday TJ, Kugler JW, Mahoney MR, Sargent DJ, Sloan JA, Fitch TR, Krook JE, O\u2019Connell MJ, Mailliard JA, Tirona MT, Tschetter LK, Cobau CD, Goldberg RM (2002) Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinoma. J Clin Oncol 20:4574\u20134580", "journal-title": "J Clin Oncol"}, {"key": "1322_CR19", "doi-asserted-by": "crossref", "first-page": "3224", "DOI": "10.1200/JCO.2006.10.4380", "volume": "25", "author": "A Gramont de", "year": "2007", "unstructured": "de Gramont A, Buyse M, Abrahantes JC, Burzykowski T, Quinaux E, Cervantes A, Figer A, Lledo G, Flesch M, Mineur L, Carola E, Etienne PL, Rivera F, Chirivella I, Perez-Staub N, Louvet C, Andr\u00e9 T, Tabah-Fisch I, Tournigand C (2007) Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer. J Clin Oncol 25:3224\u20133229", "journal-title": "J Clin Oncol"}], "container-title": ["Cancer Chemotherapy and Pharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00280-010-1322-0.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00280-010-1322-0/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00280-010-1322-0", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 1]], "date-time": "2019-06-01T00:07:30Z", "timestamp": 1559347650000}, "score": 43.451794, "issued": {"date-parts": [[2010, 7, 30]]}, "references-count": 19, "journal-issue": {"published-print": {"date-parts": [[2011, 5]]}, "issue": "5"}, "alternative-id": ["1322"], "URL": "http://dx.doi.org/10.1007/s00280-010-1322-0", "relation": {"cites": []}, "ISSN": ["0344-5704", "1432-0843"], "issn-type": [{"value": "0344-5704", "type": "print"}, {"value": "1432-0843", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}